Sensei Biotherapeutics to Participate in Oppenheimer’s 33rd Annual Healthcare Conference
BOSTON, March 06, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq:SNSE), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that Company management will present at Oppenheimer’s 33rd Annual Healthcare Conference. The presentation will be available at 8:00 a.m. ET on Monday, March 13th, 2023.
Related news for (SNSE)
- Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
- Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress
- Breaking News: MoBot’s Latest Update as of 03/28/25 10:00 AM
- Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress
- Today’s Top Performers: MoBot’s Market Review 03/28/25 09:00 AM